Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Uncertainty and CYP2C19[original query] |
---|
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 2010 Oct 304 (16): 1821-30. Mega Jessica L, Simon Tabassome, Collet Jean-Philippe, Anderson Jeffrey L, Antman Elliott M, Bliden Kevin, Cannon Christopher P, Danchin Nicolas, Giusti Betti, Gurbel Paul, Horne Benjamin D, Hulot Jean-Sebastian, Kastrati Adnan, Montalescot Gilles, Neumann Franz-Josef, Shen Lei, Sibbing Dirk, Steg P Gabriel, Trenk Dietmar, Wiviott Stephen D, Sabatine Marc |
Human Variability in Carboxylesterases and carboxylesterase-related Uncertainty Factors for Chemical Risk Assessment. Toxicology letters 2021 7 350 162-170. Di Consiglio E, Darney K, Buratti F M, Turco L, Vichi S, Testai E, Lautz L S, Dorne J L C |
Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes. Pharmaceutics 2022 12 14 (12): . Stingl Julia Carolin, Radermacher Jason, Wozniak Justyna, Viviani Rober |
CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia. Genes 2023 10 14 (10): . Malcolm Forbes, Mal Hopwood, Chad A Bousm |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: